Why primary obesity is a disease?
A De Lorenzo, S Gratteri, P Gualtieri… - Journal of translational …, 2019 - Springer
Obesity must be considered a real pathology. In the world wide, obesity represent one of the
major public health issue associated with increased morbidity and mortality. Overweight or …
major public health issue associated with increased morbidity and mortality. Overweight or …
Metabolic impact of intermittent fasting in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of interventional studies
E Borgundvaag, J Mak… - The Journal of Clinical …, 2021 - academic.oup.com
Context Intermittent fasting (IF) has been proposed as a weight-loss strategy with additional
cardiometabolic benefits in individuals with obesity. Despite its growing popularity, the effect …
cardiometabolic benefits in individuals with obesity. Despite its growing popularity, the effect …
American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with …
WT Garvey, JI Mechanick, EM Brett, AJ Garber… - Endocrine Practice, 2016 - Elsevier
Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …
Clinical Endocrinologists (AACE) Board of Directors and the American College of …
Collider bias is only a partial explanation for the obesity paradox
Background:“Obesity paradox” refers to an association between obesity and reduced
mortality (contrary to an expected increased mortality). A common explanation is collider …
mortality (contrary to an expected increased mortality). A common explanation is collider …
Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in …
F Zaccardi, NN Dhalwani, D Papamargaritis, DR Webb… - Diabetologia, 2017 - Springer
Aims/hypothesis The relationship between BMI and mortality has been extensively
investigated in the general population; however, it is less clear in people with type 2 …
investigated in the general population; however, it is less clear in people with type 2 …
[HTML][HTML] Gold nanoparticles synthesized with Smilax glabra rhizome modulates the anti-obesity parameters in high-fat diet and streptozotocin induced obese diabetes …
Diabetes is a major emerging health consequence across the world which directly
associated with the obesity. Contemporary anti-diabetic drugs have numeral limitations, and …
associated with the obesity. Contemporary anti-diabetic drugs have numeral limitations, and …
Prevalence of chronic complications, their risk factors, and the cardiovascular risk factors among patients with type 2 diabetes attending the diabetic clinic at a tertiary …
MH Arambewela, NP Somasundaram… - Journal of diabetes …, 2018 - Wiley Online Library
Diabetes incurs heavy burden to patients and the healthcare system. Assessment of disease
burden is important in taking necessary precautions and management decisions. We aimed …
burden is important in taking necessary precautions and management decisions. We aimed …
Body mass index-related mortality in patients with type 2 diabetes and heterogeneity in obesity paradox studies: a dose-response meta-analysis
Y Kwon, HJ Kim, S Park, YG Park, KH Cho - PLoS One, 2017 - journals.plos.org
Objective We conducted a systematic review and meta-analysis of studies to quantify the
association between body mass index (BMI) and the risks of all-cause and cardiovascular …
association between body mass index (BMI) and the risks of all-cause and cardiovascular …
[HTML][HTML] The evidence for an obesity paradox in type 2 diabetes mellitus
SJ Han, EJ Boyko - Diabetes & Metabolism Journal, 2018 - ncbi.nlm.nih.gov
Although overweight/obesity is a major risk factor for the development of type 2 diabetes
mellitus, there is increasing evidence that overweight or obese patients with type 2 diabetes …
mellitus, there is increasing evidence that overweight or obese patients with type 2 diabetes …
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS
Background Obesity is a risk factor for type 2 diabetes (T2D) and cardiovascular disease
(CVD). Whether obesity affects outcomes among those with T2D and atherosclerotic CVD …
(CVD). Whether obesity affects outcomes among those with T2D and atherosclerotic CVD …